North America dominates the orthobiologics market owing to the developed healthcare infrastructure and high adoption of advanced treatment methods in healthcare facilities. Furthermore, the presence of leading industry players and favorable reimbursement policies also play a crucial role in driving market growth. However, the Asia-Pacific region is projected to witness the highest growth rate during the forecast period.
New Delhi, May 20, 2022 (GLOBE NEWSWIRE) — The global orthobiologics market is growing on account of the result of changing lifestyles and the rising rate of traffic and other forms of accidents along with the growing adoption of orthobiologics treatment among athletes…
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global orthobiologics market was worth USD 6.2 billion in the year 2021. It is estimated to grow at a CAGR of 5.20%, earning revenue of around USD 8.8 billion by the end of 2028. The global orthobiologics market is gaining significant traction owing to the rising incidence of broken bones and damaged muscles, tendons, and ligaments as a result of changing lifestyles and the rising rate of traffic and other forms of accidents, the market is booming. The growing adoption of orthobiologics among athletes is also propelling the industry forward. However, the high cost of global orthobiologics market may act as a major restraining factor for the market growth.
Rising Adoption of Orthobiologics in Sports Industry is Propelling Overall Market Growth
The frequency of broken bones and injured muscles are very common among athletes. However, longer resting periods can effectively sabotage the career of the athletes. Therefore, orthobiologics treatment is being suggested to them. This treatment is gaining huge traction in the sports industry. For instance, the American Medical Society for Sports Medicine (AMSSM) has released a position statement on Principles for the Responsible Use of Regenerative Medicine in Sports Medicine, which includes orthobiologics as well.
Request for Sample Report @ https://www.blueweaveconsulting.com/report/global-orthobiologics-market/report-sample
Increasing Demand for Orthopedic Surgery is Driving Orthobiologics Market
The demand for orthopedic surgery is increasing at a high rate owing to the rising demand for the treatment of musculoskeletal trauma, spine diseases, sports injuries, degenerative diseases, infections, tumors, and congenital disorders. The favorable reimbursement policies in first-world countries and low-cost treatment in emerging economies are significantly influencing the demand for orthopedic surgery. This is anticipated to fuel the demand for orthobiologics in the forecast period.
Orthobiologics Market – By End-User
Based on end-user, the orthobiologics market is segmented into hospitals, orthopedic clinics, & ambulatory care centers, research & academic institutes, dental clinics, and facilities. The hospitals, orthopedic clinics, & ambulatory care centers account for the largest market share. A key element contributing to the market share domination is the increasing acceptance of orthobiologic products in a wide range of spinal and reconstructive procedures conducted in hospitals. Furthermore, the availability of a wide range of orthobiologics products in hospitals also plays a crucial role in driving market growth.
Orthobiologics Market – Regional Insights
Geographically, the orthobiologics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. Because of its established healthcare infrastructure and high adoption of innovative treatment procedures in healthcare institutions, North America dominates the orthobiologics industry. Furthermore, the presence of major industry competitors as well as advantageous reimbursement policies is important factors in driving market expansion. However, the Asia-Pacific region is projected to witness the highest growth rate during the forecast period.
Please Visit Press Release of Orthobiologics Market: https://www.blueweaveconsulting.com/press-release/orthobiologics-market-is-forecast-to-touch-usd-8-8-billion-by-2028
Impact of COVID-19 on Orthobiologics Market
The COVID-19 pandemic slowed the expansion of the orthobiologics sector dramatically. Due to limits on transportation and athletic activities, the risk of accidents decreased considerably as the countries implemented stringent lockdowns to prevent the virus from spreading. This has a direct influence on hospitals and other healthcare institutions’ need for orthobiologics. The market was also constrained by limits in research and development operations, as the pharmaceutical industry’s research focus turned to COVID-19 treatment and vaccine development.
The leading market players of the orthobiologics market are Arthrex Inc., Seaspine Holdings Corporation, Sanofi, Bone Support, DePuy Synthes, Integra Lifesciences, Globus Medical Inc., NuVasive Inc., Terumo Corporation, Medtronic PLC, Stryker Corporation, Zimmer Biomet, Pioneer Surgical Technology, Smith & Nephew plc, Bioventus LLC, Orthofix, Inc., Genzyme, Bone Biologics, Corp., Osiris Therapeutics, Inc., and other prominent players.
The market is highly competitive with the presence of several multinational corporations and industrial giants. These companies significantly invest in research and development activities to introduce innovations into their offerings and are constantly launching new products. The adoption of competitive strategies such as partnerships, mergers, acquisitions, collaborations, etc., is also prominent in this market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the orthobiologics market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the orthobiologics market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
- In March 2022, SeaSpine Holding, a US-based advanced spinal cord technologies company, announced the launch of new orthobiologic products; NorthStar cervical facet fusion and Flash navigation lumbar facet fusion.
- In August 2021, Bioventus, a US-based orthobiologics company, announced the acquisition of CartiHeal, an Israeli medical tech company.
Scope of the Report
|Years Considered||Historical data – 2018-2021|
|Base Year – 2021|
|Forecast – 2022 – 2028|
|Facts Covered||Revenue in USD Billion|
|Market Coverage||U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia|
|Product Service/Segmentation||By Product, By Application, By End User, By Region|
|Key Players||Arthrex Inc., Seaspine Holdings Corporation, Sanofi, Bone Support, DePuy Synthes, Integra Lifesciences, Globus Medical Inc., NuVasive Inc., Terumo Corporation, Medtronic PLC, Stryker Corporation, Zimmer Biomet, Pioneer Surgical Technology, Smith & Nephew plc, Bioventus LLC, Orthofix, Inc., Genzyme, Bone Biologics, Corp., Osiris Therapeutics, Inc., and other prominent players.|
- Viscosupplementation Products
- Demineralized Bone Matrices
- Synthetic Orthobiologics
- Bone Morphogenic Protein
- Plasma-Rich Protein
- Bone Marrow Aspirate Concentrate
- Osteoarthritis and Degenerative Arthritis
- Spinal Fusion
- Soft-Tissue Injuries
- Fracture Recovery
- Maxillofacial and Dental Applications
By End User
- Hospitals, Orthopedic Clinics, & Ambulatory Care Centers
- Research & Academic Institutes
- Dental Clinics and Facilities
- North America
- Asia-Pacific (APAC)
- Latin America (LATAM)
- Middle East & Africa (MEA)
Please Find Below Some Related Topics:
- Transplant Diagnostics Market, Trend Analysis and Forecast Report, 2018-2028
- Sustained Release Coatings Market, Trend Analysis and Forecast Report, 2018-2028
- Oxygen Therapy Device Market, Trend Analysis and Forecast Report, 2018-2028
- Empty Capsules Market, Trend Analysis and Forecast Report, 2018-2028
- Pharmaceutical Excipients Market, Trend Analysis and Forecast Report, 2018-2028
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
Image Credit: Lightspring/Shutterstock.com